5. SURVEY OF SERUM PROCALCITONIN CONCENTRATIONS AND BLOOD CULTURE RESULTS IN PATIENTS WITH BACTERIA INFECTION AT A THAI NGUYEN HOSPITAL
Main Article Content
Abstract
Introduction: Procalcitonin (PCT) is a valuable biomarker commonly used to diagnose and monitor infectious inflammation. Objective: To investigate serum procalcitonin concentrations in patients with positive blood culture sepsis and to evaluate the association between serum procalcitonin concentrations and isolated bacterial pathogens.
Subjects and methods: A cross-sectional study of 278 patients diagnosed with sepsis at Thai Nguyen A Hospital from January to September 2024.
Results: The median serum PCT concentration in the positive blood culture group (22.1 ng/ml) was higher than that in the negative blood culture group (8.32 ng/ml) with p<0.05. The area under the curve was 0.682 (p<0.01), and the cut-off point for distinguishing between positive and negative blood culture sepsis was 5.4 ng/ml, with a sensitivity of 54.8% and a specificity of 80.6%. The mean serum PCT concentration of the gram-negative group was 20.6 ng/ml, higher than that of the gram-positive group at 0.7 ng/ml, with p < 0.05. The area under the curve was 0.791 with p < 0.01. The cut-off point for distinguishing between gram-positive and gram-negative bacteremia was 9.16 ng/ml, with a sensitivity of 61% and a specificity of 76.2%.
Conclusion: PCT is valuable in distinguishing between blood culture-positive and negative bacteremia and gram-negative and gram-positive bacteremia.
Article Details
Keywords
Procalcitonin, sepsis
References
[1] Singer Mervyn, Deutschman Clifford S., Seymour Christopher Warren, et al. (2016). The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315(8): 801-810.
[2] Rudd K. E., Johnson S. C., Agesa K. M., et al. (2020). Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet, 395(10219): 200-211.
[3] (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet, 399(10325): 629-655.
[4] Eranki. Derrick A. Cleland; Ambika P. (2023), Procalcitonin,StatPearls.
[5] Nguyễn Việt Phương Nguyễn Minh Hải, Nguyễn Văn Dương và CS (2017). Nghiên cứu giá trị chẩn đoán của PCT ở bệnh nhân nhiễm khuẩn huyết. Tạp chí Y Dược học Quân sự, 6-2017: 79-84.
[6] Huy Thạch Lê, Văn Thanh Lê, Thùy Dung Đỗ, et al. (2022). Nồng độ procalcitonin huyết thanh và mối liên quan với kết quả cấy máu tại bệnh viện đa khoa tỉnh Ninh Thuận năm 2021. Tạp chí Y học Việt Nam, 511(1).
[7] Trương Thị Thu Hiền, Nguyễn Thị Mai Hương, Hoàng Mỹ Hạnh (2023). Đánh giá tỷ lệ và mức độ kháng kháng sinh của các chủng vi khuẩn gây nhiễm khuẩn huyết tại Bệnh viện Bỏng Quốc gia (01/2016 - 12/2021). Tạp chí Y học Thảm hoạ và Bỏng, (1): 38-53.
[8] Yan S. T., Sun L. C., Jia H. B., et al. (2017). Procalcitonin levels in bloodstream infections caused by different sources and species of bacteria. Am J Emerg Med, 35(4): 579-583.
[9] 9. Opota O., Croxatto A., Prod'hom G., et al. (2015). Blood culture-based diagnosis of bacteraemia: state of the art. Clin Microbiol Infect, 21(4): 313-22.